vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Global-E Online Ltd. (GLBE). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($821.5M vs $625.5M, roughly 1.3× Global-E Online Ltd.). Global-E Online Ltd. runs the higher net margin — 0.9% vs -143.3%, a 144.3% gap on every dollar of revenue.
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Global-E Online Ltd. operates a leading cross-border e-commerce enablement platform that helps direct-to-consumer brands and retail enterprises expand their international sales reach. It offers end-to-end services including localized checkout, payment processing, customs clearance, logistics coordination, and duty calculation, serving clients across North America, Europe, and the Asia-Pacific region.
ACHC vs GLBE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $625.5M |
| Net Profit | $-1.2B | $5.8M |
| Gross Margin | — | 45.0% |
| Operating Margin | -142.4% | 1.3% |
| Net Margin | -143.3% | 0.9% |
| Revenue YoY | 6.1% | — |
| Net Profit YoY | -3710.4% | — |
| EPS (diluted) | $-12.98 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $625.5M | ||
| Q2 25 | $869.2M | $404.8M | ||
| Q1 25 | $770.5M | $189.9M | ||
| Q4 24 | $774.2M | — | ||
| Q3 24 | $815.6M | $489.9M | ||
| Q2 24 | $796.0M | $313.9M | ||
| Q1 24 | $768.1M | $145.9M |
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $5.8M | ||
| Q2 25 | $30.1M | $-7.4M | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $68.1M | $-77.1M | ||
| Q2 24 | $78.5M | $-54.5M | ||
| Q1 24 | $76.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 45.0% | ||
| Q2 25 | — | 44.9% | ||
| Q1 25 | — | 44.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 45.1% | ||
| Q2 24 | — | 44.8% | ||
| Q1 24 | — | 43.4% |
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 1.3% | ||
| Q2 25 | 5.8% | -2.1% | ||
| Q1 25 | 1.7% | -10.1% | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | -14.9% | ||
| Q2 24 | 13.4% | -16.6% | ||
| Q1 24 | 12.9% | -20.1% |
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | 0.9% | ||
| Q2 25 | 3.5% | -1.8% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 8.4% | -15.7% | ||
| Q2 24 | 9.9% | -17.4% | ||
| Q1 24 | 9.9% | — |
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | — | ||
| Q2 25 | $0.33 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.74 | — | ||
| Q2 24 | $0.85 | — | ||
| Q1 24 | $0.83 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $251.4M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $1.9B | $933.0M |
| Total Assets | $5.5B | $1.3B |
| Debt / EquityLower = less leverage | 1.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | $251.4M | ||
| Q2 25 | $131.4M | $205.2M | ||
| Q1 25 | $91.2M | $207.7M | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | $207.3M | ||
| Q2 24 | $77.2M | $229.8M | ||
| Q1 24 | $77.3M | $181.9M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $933.0M | ||
| Q2 25 | $3.1B | $909.1M | ||
| Q1 25 | $3.0B | $884.3M | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.0B | $869.4M | ||
| Q2 24 | $3.0B | $878.7M | ||
| Q1 24 | $2.9B | $886.9M |
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $1.3B | ||
| Q2 25 | $6.3B | $1.2B | ||
| Q1 25 | $6.1B | $1.2B | ||
| Q4 24 | $6.0B | — | ||
| Q3 24 | $5.9B | $1.2B | ||
| Q2 24 | $5.7B | $1.1B | ||
| Q1 24 | $5.5B | $1.1B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | — |
| Free Cash FlowOCF − Capex | $-179.5M | — |
| FCF MarginFCF / Revenue | -21.8% | — |
| Capex IntensityCapex / Revenue | 11.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | — | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $116.7M | — | ||
| Q3 24 | $163.1M | — | ||
| Q2 24 | $171.1M | — | ||
| Q1 24 | $-321.3M | — |
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $-463.7M | — |
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -60.4% | — |
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — | ||
| Q1 24 | 18.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
GLBE
Segment breakdown not available.
